loading...

Novartis NIBR Dermatitis study. Reimagine medicine to improve the health of your skin

Help us to find a better treatment for atopic dermatitis

Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory skin condition characterized by intense itching (pruritus) and eczematous lesions.

Learn more about clinical trials at Novartis here

AD is a leading non-fatal health burden attributable to skin disease worldwide and can cause significant physical, psychological, and economic burden to patients, carers, and health systems alike. It is estimated to affect 5-10% of adults and 11-20% of children. Approximately 50% of patients with AD experience moderate to severe disease which requires treatment with systemic therapy. Despite advances in systemic therapies for moderate to severe AD, there remains a large unmet need for treatments that achieve high levels of skin clearance and itch relief with a safety profile suitable for long-term use. The aim of this study is to improve existing treatment options for current AD patients.

{{ failureMessage }}

Check if you are eligible to participate today!

The personal data submitted via this form will be retained ONLY for the purpose of responding to your question or concern and will not be used for any marketing purposes.

{{ errors.email[0] }}

Novartis values and is fully committed to protecting the privacy and security of your information gathered in connection with this project. Novartis follows federal and state regulations governing the collection and use of an individual's data. Should you decide to participate in the study, all identifiable information obtained from this research will remain strictly confidential within the limits of the law.

Personal data provided via this website will only be used by the study team to contact you. Should you decide not to participate in the study, all personal data will be deleted immediately.

How will the study benefit me?

Access to atopic dermatitis medical care

Access to an investigational drug which may improve your condition and quality of life

The opportunity to help researchers find out more about your condition and contribute to medical knowledge that may help other people in the future

Novartis NIBR Dermatitis study. Reimagine medicine to improve the health of your skin